{
  "DOI": "10.1007/s10689-011-9418-1",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-011-9418-1",
  "alternative-id": [
    "9418"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Daniels",
      "given": "Molly S.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Burzawa",
      "given": "Jennifer K.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Brandt",
      "given": "Amanda C.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Schmeler",
      "given": "Kathleen M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lu",
      "given": "Karen H.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2011,
        1,
        18
      ]
    ],
    "date-time": "2011-01-18T11:15:27Z",
    "timestamp": 1295349327000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:46:05Z",
    "timestamp": 1559252765000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        3
      ]
    ],
    "date-time": "2023-10-03T11:26:28Z",
    "timestamp": 1696332388244
  },
  "is-referenced-by-count": 9,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2011,
        1,
        19
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2011,
          6
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2011,
            1,
            19
          ]
        ],
        "date-time": "2011-01-19T00:00:00Z",
        "timestamp": 1295395200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-011-9418-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-011-9418-1/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-011-9418-1",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "193-197",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2011,
        1,
        19
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2011,
        1,
        19
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2011,
        6
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/j.ejca.2003.09.016",
      "author": "S Malander",
      "doi-asserted-by": "crossref",
      "first-page": "422",
      "issue": "3",
      "journal-title": "Eur J Cancer",
      "key": "9418_CR1",
      "unstructured": "Malander S et al (2004) One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. Eur J Cancer 40(3):422–428",
      "volume": "40",
      "year": "2004"
    },
    {
      "DOI": "10.1002/cncr.21536",
      "author": "T Pal",
      "doi-asserted-by": "crossref",
      "first-page": "2807",
      "issue": "12",
      "journal-title": "Cancer",
      "key": "9418_CR2",
      "unstructured": "Pal T et al (2005) BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104(12):2807–2816",
      "volume": "104",
      "year": "2005"
    },
    {
      "DOI": "10.1086/318787",
      "author": "HA Risch",
      "doi-asserted-by": "crossref",
      "first-page": "700",
      "issue": "3",
      "journal-title": "Am J Hum Genet",
      "key": "9418_CR3",
      "unstructured": "Risch HA et al (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68(3):700–710",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-06-1114",
      "author": "H Hampel",
      "doi-asserted-by": "crossref",
      "first-page": "7810",
      "issue": "15",
      "journal-title": "Cancer Res",
      "key": "9418_CR4",
      "unstructured": "Hampel H et al (2006) Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66(15):7810–7817",
      "volume": "66",
      "year": "2006"
    },
    {
      "DOI": "10.1056/NEJMoa043146",
      "author": "H Hampel",
      "doi-asserted-by": "crossref",
      "first-page": "1851",
      "issue": "18",
      "journal-title": "N Engl J Med",
      "key": "9418_CR5",
      "unstructured": "Hampel H et al (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352(18):1851–1860",
      "volume": "352",
      "year": "2005"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-07-2308",
      "author": "H Hampel",
      "doi-asserted-by": "crossref",
      "first-page": "9603",
      "issue": "19",
      "journal-title": "Cancer Res",
      "key": "9418_CR6",
      "unstructured": "Hampel H et al (2007) Comment on: screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 67(19):9603",
      "volume": "67",
      "year": "2007"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-06-0503",
      "author": "KE Malone",
      "doi-asserted-by": "crossref",
      "first-page": "8297",
      "issue": "16",
      "journal-title": "Cancer Res",
      "key": "9418_CR7",
      "unstructured": "Malone KE et al (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 66(16):8297–8308",
      "volume": "66",
      "year": "2006"
    },
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1117",
      "issue": "5",
      "journal-title": "Am J Hum Genet",
      "key": "9418_CR8",
      "unstructured": "Antoniou A et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130",
      "volume": "72",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2006.09.1066",
      "author": "S Chen",
      "doi-asserted-by": "crossref",
      "first-page": "1329",
      "issue": "11",
      "journal-title": "J Clin Oncol",
      "key": "9418_CR9",
      "unstructured": "Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329–1333",
      "volume": "25",
      "year": "2007"
    },
    {
      "author": "DF Easton",
      "first-page": "265",
      "issue": "1",
      "journal-title": "Am J Hum Genet",
      "key": "9418_CR10",
      "unstructured": "Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast cancer linkage consortium. Am J Hum Genet 56(1):265–271",
      "volume": "56",
      "year": "1995"
    },
    {
      "DOI": "10.1086/301749",
      "author": "D Ford",
      "doi-asserted-by": "crossref",
      "first-page": "676",
      "issue": "3",
      "journal-title": "Am J Hum Genet",
      "key": "9418_CR11",
      "unstructured": "Ford D et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676–689",
      "volume": "62",
      "year": "1998"
    },
    {
      "DOI": "10.1200/JCO.2007.13.9626",
      "author": "ND Kauff",
      "doi-asserted-by": "crossref",
      "first-page": "1331",
      "issue": "8",
      "journal-title": "J Clin Oncol",
      "key": "9418_CR12",
      "unstructured": "Kauff ND et al (2008) Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol 26(8):1331–1337",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1001/jama.2010.1237",
      "author": "SM Domchek",
      "doi-asserted-by": "crossref",
      "first-page": "967",
      "issue": "9",
      "journal-title": "JAMA",
      "key": "9418_CR13",
      "unstructured": "Domchek SM et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975",
      "volume": "304",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2008.21.4684",
      "author": "JS Kwon",
      "doi-asserted-by": "crossref",
      "first-page": "675",
      "issue": "4",
      "journal-title": "J Clin Oncol",
      "key": "9418_CR14",
      "unstructured": "Kwon JS et al (2010) Preventing future cancers by testing women with ovarian cancer for BRCA mutations. J Clin Oncol 28(4):675–682",
      "volume": "28",
      "year": "2010"
    },
    {
      "key": "9418_CR15",
      "unstructured": "Ozols RF et al 2005 Epithelial ovarian cancer, in principles and practice of gynecologic oncology. In: Hoskins WJ et al (ed) Lippincott Williams and Wilkins, Philadelphia, pp 895–988"
    },
    {
      "DOI": "10.1097/AOG.0b013e3181da08d7",
      "author": "LA Meyer",
      "doi-asserted-by": "crossref",
      "first-page": "945",
      "issue": "5",
      "journal-title": "Obstet Gynecol",
      "key": "9418_CR16",
      "unstructured": "Meyer LA et al (2010) Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. Obstet Gynecol 115(5):945–952",
      "volume": "115",
      "year": "2010"
    },
    {
      "DOI": "10.1097/GIM.0b013e3181ab2295",
      "author": "MS Daniels",
      "doi-asserted-by": "crossref",
      "first-page": "624",
      "issue": "9",
      "journal-title": "Genet Med",
      "key": "9418_CR17",
      "unstructured": "Daniels MS et al (2009) Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer. Genet Med 11(9):624–628",
      "volume": "11",
      "year": "2009"
    },
    {
      "DOI": "10.1179/096992604225005263",
      "author": "J Kirk",
      "doi-asserted-by": "crossref",
      "first-page": "59",
      "issue": "2",
      "journal-title": "Prog Palliat Care",
      "key": "9418_CR18",
      "unstructured": "Kirk J (2004) The family history of cancer: a common concern in palliative care. Prog Palliat Care 12(2):59–65",
      "volume": "12",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.ygyno.2008.06.016",
      "author": "RA Lacour",
      "doi-asserted-by": "crossref",
      "first-page": "132",
      "issue": "1",
      "journal-title": "Gynecol Oncol",
      "key": "9418_CR19",
      "unstructured": "Lacour RA et al (2008) What women with ovarian cancer think and know about genetic testing. Gynecol Oncol 111(1):132–136",
      "volume": "111",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S0140-6736(10)60893-8",
      "author": "MW Audeh",
      "doi-asserted-by": "crossref",
      "first-page": "245",
      "issue": "9737",
      "journal-title": "Lancet",
      "key": "9418_CR20",
      "unstructured": "Audeh MW et al (2010) Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet 376(9737):245–251",
      "volume": "376",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.ygyno.2005.09.005",
      "author": "VE Gruenigen von",
      "doi-asserted-by": "crossref",
      "first-page": "255",
      "issue": "2",
      "journal-title": "Gynecol Oncol",
      "key": "9418_CR21",
      "unstructured": "von Gruenigen VE, Daly BJ (2005) Treating ovarian cancer patients at the end of life: when should we stop? Gynecol Oncol 99(2):255–256",
      "volume": "99",
      "year": "2005"
    },
    {
      "DOI": "10.1007/s10897-010-9308-y",
      "author": "J Quillin",
      "doi-asserted-by": "crossref",
      "first-page": "497",
      "issue": "5",
      "journal-title": "J Genet Couns",
      "key": "9418_CR22",
      "unstructured": "Quillin J et al (2010) Exploring hereditary cancer among dying cancer patients—a cross-sectional study of hereditary risk and perceived awareness of DNA testing and banking. J Genet Couns 19(5):497–525",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1089/jpm.2007.0150",
      "author": "JM Quillin",
      "doi-asserted-by": "crossref",
      "first-page": "451",
      "issue": "3",
      "journal-title": "J Palliat Med",
      "key": "9418_CR23",
      "unstructured": "Quillin JM, Bodurtha JN, Smith TJ (2008) Genetics assessment at the end of life: suggestions for implementation in clinic and future research. J Palliat Med 11(3):451–458",
      "volume": "11",
      "year": "2008"
    },
    {
      "DOI": "10.12968/ijpn.2006.12.2.20533",
      "author": "AK Lillie",
      "doi-asserted-by": "crossref",
      "first-page": "70",
      "issue": "2",
      "journal-title": "Int J Palliat Nurs",
      "key": "9418_CR24",
      "unstructured": "Lillie AK (2006) Exploring cancer genetics and care of the family: an evolving challenge for palliative care. Int J Palliat Nurs 12(2):70–74",
      "volume": "12",
      "year": "2006"
    }
  ],
  "reference-count": 24,
  "references-count": 24,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-011-9418-1"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges"
  ],
  "type": "journal-article",
  "volume": "10"
}